Peter Lynch · Growth at a reasonable price (GARP)
Is Aurinia Pharmaceuticals Inc. (AUPH) a Peter Lynch Stock?
Strong GARP candidate: growth at a reasonable price.
81/100
Encaixa
4/6 critérios atendidos
Os critérios de Peter Lynch, aplicados a AUPH
PEG ≤ 1.0
chave-
EPS CAGR ≥ 15%
chave-
Revenue CAGR ≥ 10%
57.8%
Net margin > 0
100.0%
Como AUPH pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$2.11B
P/L (TTM)
6.8x
ROIC (TTM)
18.99%
Margem bruta
89.74%
Outras análises Peter Lynch
Perguntas frequentes
What is AUPH's Peter Lynch fit score?
AUPH scores 81/100 on our Peter Lynch fit engine. Strong GARP candidate: growth at a reasonable price.
Does Peter Lynch actually own AUPH?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends AUPH.
How often is this score updated?
AUPH's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Peter Lynch possua ou recomende AUPH pessoalmente.
